Fasedienol

N/A

Report date: 2023/08/22 17:03:10
NME

Base Information

Drug NameFasedienol
Drug Alias NameAloradine INAloradine NSFasedienolPH-94BPH-94B-NS +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSensory receptor modulatorsGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSocial Communication DisorderPhobia, SocialAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPherin Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEverInsight Therapeutics IncVistagen Therapeutics IncAffamed Therapeutics Ltd
Inactive CompaniesPherin Pharmaceuticals Inc
Active IndicationsSocial Communication DisorderPhobia, SocialAnxiety
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank